(VIANEWS) - Halozyme Therapeutics (HALO), Esquire Financial Holdings (ESQ), Quidel (QDEL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Halozyme Therapeutics (HALO)
68.1% sales growth and 111.55% return on equity
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. Its flagship product is Hylenex recombinant, a formulation of rHuPH20 to facilitate subcutaneous fluid administration for achieving hydration to enhance the dispersion and absorption of other injected drugs in subcutaneous urography and to improve resorption of radiopaque agents. The company also develops Perjeta; RITUXAN HYCELA and MabThera SC for the treatment of non-Hodgkin lymphoma and chronic lymphocytic leukemia (CLL); RITUXAN SC for patients with CLL; and HYQVIA for the treatment of immunodeficiency disorders. In addition, it is developing Tecentriq for non-small cell lung cancer; OCREVUS for multiple sclerosis; DARZALEX for the treatment of patients with amyloidosis, smoldering myeloma, and multiple myeloma; nivolumab for the treatment of solid tumors; ARGX-113, a human neonatal Fc receptor; ARGX-117 to treat autoimmune diseases; and BMS-986179, an anti-CD-73 antibody. The company has collaborations with F. Hoffmann-La Roche, Ltd.; Hoffmann-La Roche, Inc.; Baxalta US Inc.; Baxalta GmbH; Pfizer Inc.; Janssen Biotech, Inc.; AbbVie, Inc.; Eli Lilly and Company; Bristol-Myers Squibb Company; Alexion Pharma Holding; ARGENX BVBA; Horizon Therapeutics plc; National Institute of Allergy and Infectious Diseases; Centre for the AIDS Programme of Research in South Africa; and ViiV Healthcare Limited for small and large molecule targets for the treatment and prevention of HIV. Halozyme Therapeutics, Inc. was founded in 1998 and is based in San Diego, California.
Earnings Per Share
As for profitability, Halozyme Therapeutics has a trailing twelve months EPS of $1.53.
PE Ratio
Halozyme Therapeutics has a trailing twelve months price to earnings ratio of 33.54. Meaning, the purchaser of the share is investing $33.54 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 111.55%.Yearly Top and Bottom Value
Halozyme Therapeutics's stock is valued at $51.32 at 10:22 EST, way below its 52-week high of $59.46 and way above its 52-week low of $31.36.
Growth Estimates Quarters
The company's growth estimates for the present quarter and the next is 11.9% and 31.9%, respectively.2. Esquire Financial Holdings (ESQ)
37.3% sales growth and 18.29% return on equity
Esquire Financial Holdings, Inc. operates as the bank holding company for Esquire Bank, National Association that provides commercial banking products and services to legal industry and small businesses, and commercial and retail customers in the United States. The company offers checking, savings, money market, and time deposits, as well as certificates of deposit. It also provides commercial loans, including short-term financing for inventory, receivables, the purchase of supplies, or other operating needs arising during the normal course of business, as well as loans to its qualified merchant customers; commercial lines of credit; consumer loans consisting of post-settlement consumer and structured settlement loans to plaintiffs and claimants, as well as loans to individuals for debt consolidation, medical expenses, living expenses, payment of outstanding bills, or other consumer needs; and real estate loans, such as multifamily, 1-4 family residential, commercial real estate, and construction loans, as well as merchant services. As of December 31, 2020, the company operated a full-service branch in Jericho, New York; and an administrative office in Boca Raton, Florida. Esquire Financial Holdings, Inc. was founded in 2006 and is headquartered in Jericho, New York.
Earnings Per Share
As for profitability, Esquire Financial Holdings has a trailing twelve months EPS of $1.86.
PE Ratio
Esquire Financial Holdings has a trailing twelve months price to earnings ratio of 22.23. Meaning, the purchaser of the share is investing $22.23 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 18.29%.3. Quidel (QDEL)
20.9% sales growth and 31.79% return on equity
QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; and analyzers and amplification systems. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was founded in 1979 and is headquartered in San Diego, California.
Earnings Per Share
As for profitability, Quidel has a trailing twelve months EPS of $18.6.
PE Ratio
Quidel has a trailing twelve months price to earnings ratio of 4.59. Meaning, the purchaser of the share is investing $4.59 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 31.79%.Sales Growth
Quidel's sales growth is 41.2% for the current quarter and 20.9% for the next.
Growth Estimates Quarters
The company's growth estimates for the current quarter and the next is a negative 86.2% and a negative 82.7%, respectively.4. Grupo Televisa S.A. (TV)
15% sales growth and 8.46% return on equity
Grupo Televisa, S.A.B. operates as a media company in the Spanish-speaking world. The company operates in four segments: Cable, Sky, Content, and Other Businesses. The Cable segment operates cable multiple system and telecommunication facilities. It provides basic and premium television subscription, pay-per-view, installation, Internet subscription, and telephone and mobile services subscription, as well as local and national advertising sales; and data and long-distance services solutions to carriers and other telecommunications service providers through its fiber-optic network. The Sky segment offers direct-to-home broadcast satellite pay television services comprising program, installation, and equipment rental services to subscribers in Mexico, Central America, and the Dominican Republic; and national advertising sales. The Content segment produces television programming and broadcasts Channels 2, 4, 5, and 9; sells advertising time on programs; provides Internet services; and produces television programming and broadcasting for local television stations in Mexico. It also offers programming services for cable and pay-per-view television companies in Mexico, other countries in Latin America, the United States, and Europe; and licenses and syndicates television programming. The Other Businesses segment is involved in sports and show business promotion, soccer, feature film production and distribution, gaming, publishing, and publishing distribution businesses. Grupo Televisa, S.A.B. was founded in 1969 and is headquartered in Mexico City, Mexico.
Earnings Per Share
As for profitability, Grupo Televisa S.A. has a trailing twelve months EPS of $0.95.
PE Ratio
Grupo Televisa S.A. has a trailing twelve months price to earnings ratio of 5.93. Meaning, the purchaser of the share is investing $5.93 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.46%.Earnings Before Interest, Taxes, Depreciation, and Amortization
Grupo Televisa S.A.'s EBITDA is 1.91.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on May 25, 2022, the estimated forward annual dividend rate is 0.09 and the estimated forward annual dividend yield is 1.65%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 3.6%, now sitting on 104.83B for the twelve trailing months.
5. WillScot Mobile Mini Holdings Corp. (WSC)
9.6% sales growth and 13.75% return on equity
WillScot Mobile Mini Holdings Corp. provides modular space and portable storage solutions in the United States, Canada, Mexico, and the United Kingdom. The company leases various office space and storage solutions for temporary applications across a customer base in the commercial and industrial, construction, retail, education, health care, government, transportation, security, and energy sectors. . It operates a fleet of over 350,000 portable offices and storage containers. The company is headquartered in Phoenix, Arizona.
Earnings Per Share
As for profitability, WillScot Mobile Mini Holdings Corp. has a trailing twelve months EPS of $-0.1.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.75%.6. Costco (COST)
5.1% sales growth and 30.55% return on equity
Costco Wholesale Corporation, together with its subsidiaries, engages in the operation of membership warehouses in the United States, Puerto Rico, Canada, the United Kingdom, Mexico, Japan, Korea, Australia, Spain, France, Iceland, China, and Taiwan. It offers branded and private-label products in a range of merchandise categories. The company offers sundries, dry groceries, candies, coolers, freezers, liquor, and tobacco and deli products; appliances, electronics, health and beauty aids, hardware, garden and patio products, sporting goods, tires, toys and seasonal products, office supplies, automotive care products, postages, tickets, apparel, small appliances, furniture, domestics, housewares, special order kiosks, and jewelry; and meat, produce, service deli, and bakery products. It also operates pharmacies, optical, food courts, hearing aids, and tire installation centers, as well as 668 gas stations; and offers online business delivery, travel, same-day grocery, and various other services. As of August 28, 2022, the company operated 838 membership warehouses, including 578 in the United States and Puerto Rico, 107 in Canada, 40 in Mexico, 31 in Japan, 29 in the United Kingdom, 17 in Korea, 14 in Taiwan, 13 in Australia, 4 in Spain, 1 in Iceland, 2 in France, and 2 in China. It also operates e-commerce websites in the United States, Canada, the United Kingdom, Mexico, Korea, Taiwan, Japan, and Australia. The company was formerly known as Costco Companies, Inc. and changed its name to Costco Wholesale Corporation in August 1999. Costco Wholesale Corporation was founded in 1976 and is based in Issaquah, Washington.
Earnings Per Share
As for profitability, Costco has a trailing twelve months EPS of $9.78.
PE Ratio
Costco has a trailing twelve months price to earnings ratio of 51.55. Meaning, the purchaser of the share is investing $51.55 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 30.55%.